Global High-Priority Regulatory Events — April 06, 2026

06-04-2026

RBI reported zero volumes in all overnight and term money market segments on April 3, 2026. Today's RBI operations under LAF, MSF, and SDF resulted in net liquidity absorption of ₹4,01,865 Cr, with overall net liquidity (including outstanding operations) at -₹3,47,834 Cr absorption. Scheduled commercial banks held cash reserves of ₹8,05,197 Cr against an average CRR requirement of ₹7,76,432 Cr.

• ·Money market volumes (overnight and term segments): 0.00 across all categories including Call Money, Triparty Repo, Market Repo, and Repo in Corporate Bonds.
• ·Government of India surplus cash balance reckoned for auction as on Apr 2: ₹0 Cr.
• ·MSF rate: 5.50%, SDF rate: 5.00%.

06-04-2026

Reliance Home Finance Limited's Resolution Professional, Umesh B. Sonkar, intimated stock exchanges about the 8th Meeting of the Committee of Creditors (CoC), held on April 03, 2026, at 04:30 P.M. IST via video conferencing. This update is part of the ongoing Corporate Insolvency Resolution Process (CIRP) initiated on or before September 20, 2025. No outcomes or decisions from the meeting were disclosed.

• ·BSE Scrip Code: 540709; NSE Symbol: RHFL; ISIN: INE217K01011
• ·RP Contact: 7874447169, 8433628134; Email: rosonkar1603@gmail.com; CIRP Email: cirp.rhfl@yahoo.com
• ·RP Registration: MAH/7972/2019 and IBBI/IPA-001/P-02619/2021-2022/14043; Valid upto December 31, 2026

06-04-2026

Ratnamani Metals & Tubes Limited informed BSE and NSE on April 6, 2026, about the publication of a newspaper advertisement announcing the Second Special Window for transfer and dematerialization of physical shares and the Second 100 days Campaign – “Saksham Niveshak” for KYC updation and shareholder engagement to prevent transfer of unpaid/unclaimed dividends to IEPF. The ad appeared in Financial Express (English and Gujarati editions) and is available on the company's website www.ratnamani.com. This is an administrative shareholder notice with no financial impact disclosed.

• ·Company codes: 520111 (BSE), RATNAMANI (NSE)
• ·Advertisement published in Financial Express English Edition and Gujarati Edition on April 6, 2026

06-04-2026

BlackRock, Inc. (on behalf of discretionary management clients) disclosed under SEBI Regulation 29(2) a decrease in its aggregate holdings percentage in Sammaan Capital Ltd from 7.76% to 5.53%, while the number of shares held remained flat at 63,374,844. This dilution resulted from the company's equity share capital expansion from 815,813,760 to 1,145,813,871 shares following an allotment intimation on April 1, 2026. No shares were bought or sold by BlackRock during this period.

• ·Disclosure made to BSE on April 3, 2026; filing date April 6, 2026
• ·No encumbrances, warrants, or other voting rights instruments held
• ·Mode of change: Allotment of Equity Shares

06-04-2026

East India Drums and Barrels Manufacturing Ltd received a Letter of Acceptance from Bharat Petroleum Corporation Limited (BPCL) for supplying metallic drums/barrels with an aggregate contract value of ₹1,06,00,000. Supplies will be delivered to BPCL's Mumbai Refinery at Mahul, India. This order strengthens the company's long-standing relationship with BPCL and underscores its manufacturing capabilities and quality standards.

• ·Disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• ·Scrip Code: 523874
• ·Filing Date: April 06, 2026

06-04-2026

RO Jewels Limited filed an annual disclosure of encumbrance pursuant to Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for the financial year ended March 31, 2026. The disclosure was received from Mr. Shubham Shah, Promoter and Managing Director, on behalf of the Promoter & Promoter Group and PAC of the company. No specific details on the nature or extent of the encumbrance are included in the filing notice.

• ·Filing submitted to BSE Limited on April 06, 2026.
• ·Company CIN: L74999GJ2018PLC105540; Registered Office: Common,131/A, Ganchi S Pole, M G Haveli RD, Manek Chowk, Ahmedabad, Gujarat, 380001.

06-04-2026

Santosh Fine-Fab Ltd. (Scrip Code: 530035) has intimated BSE Limited of a Board of Directors meeting scheduled for April 13, 2026, at 4:30 PM at the registered office. The agenda includes considering the resignation of Ms. Niti Jain as Company Secretary & Compliance Officer and approving the appointment of Ms. Radha Sharma to the same position. Any other business may be taken up with the Chair's permission.

• ·Filing Date: April 06, 2026
• ·Meeting Venue: Registered office of the company
• ·CIN: L17112MH1981PLC025443
• ·Contact: +91 91360 75880 / 022 2850 4759 / 022-2850 2411, sales@sontoshgroup.in

06-04-2026

Profusa, Inc. entered into a non-binding Letter of Intent (LOI), dated March 31, 2026, as amended April 4, 2026, to acquire Bio Insights LLC's PanOmics assets for $30 million in stock, including 460,000 common shares at closing (capped at 19.99% of outstanding shares) and preferred stock convertible into 59,540,000 common shares after one year. The deal includes plans for $10 million in additional equity financing, allocation of up to $2 million for PanOmics validation, 3% net revenue royalties to Bio Insights, and board nomination rights, but remains subject to due diligence, definitive agreements by May 1, 2026, and shareholder approval before June 30, 2026.

• ·LOI terminates automatically on May 1, 2026, unless extended or definitive agreements executed.
• ·Exclusivity period prevents Bio Insights from engaging with other parties on similar transactions.
• ·Lock-up on conversion shares for 7 years with annual 1/7th releases and tax liability carve-out.
• ·Samples: Cohort 1 ([***] samples) within 5 business days post-closing; Cohort 2 ([***] samples) within 30 days post-MTA.

06-04-2026

The Charles Schwab Corporation's 2026 Proxy Statement details the board of directors' composition, with 13 independent directors across four standing committees: Audit (13 meetings in 2025), Compensation (6 meetings), Nominating and Corporate Governance (4 meetings), and Risk (6 meetings), all chaired by independents except Risk which is chaired by an independent. Gerri K. Martin-Flickinger's term expires at the annual meeting without re-election, while Charles A. Ruffel joined the Audit Committee and left the Risk Committee effective March 31, 2026. The statement emphasizes board qualifications, diversity of experience, and governance policies including prohibitions on speculative trading, hedging, and pledging.

• ·Audit Committee members determined financially literate per NYSE standards; John K. Adams, Jr. and Stephen A. Ellis designated Audit Committee financial experts per SEC rules.
• ·Insider Trading Policy prohibits speculative trading, certain hedging, short-term transactions (except ESPP), and pledging of company securities.
• ·Corporate Governance Guidelines outline director qualifications emphasizing business experience, independence, diversity, and time commitment.

06-04-2026

MAA's 2026 Proxy Statement seeks shareholder approval for electing nine directors (board size decreasing from prior levels), advisory approval of 2025 executive compensation reflecting mixed incentive performance (Core FFO per share of $8.77 exceeded target of $8.74 and FAD of $696.08M exceeded $685.71M target, but SS NOI growth of -1.36% missed -1.15% target and 3-yr TSR of -1.47% underperformed 4.07% target), and ratification of Ernst & Young LLP as independent auditors with total fees declining 13% YoY to $2,476,798. Director nominees feature diverse expertise in real estate, finance, and operations, with strong independence (7/9 independent). The Board highlights proactive succession planning and governance practices.

• ·No 2023 LTIP or 2025 LTIP TSR/3-YR TSR awards earned (payout $0).
• ·Audit Committee has three financial experts; all members independent.
• ·Annual Meeting date: May 19, 2026.

06-04-2026

Westlake Corporation entered into a new Credit Agreement dated April 2, 2026, with JPMorgan Chase Bank, N.A. as Administrative Agent and a syndicate of lenders including joint bookrunners BofA Securities, Inc., Wells Fargo Securities, LLC, and Deutsche Bank Securities Inc. The facility supports revolving borrowings and letters of credit in Agreed Currencies, with an Alternate Currency Sublimit of $1.5 billion and pricing at Level III based on public debt ratings (equivalent to BBB/Baa2/BBB). No performance declines or comparisons are disclosed in the filing.

• ·Filing date: April 6, 2026
• ·Current Applicable Rate at Pricing Level III: Term Benchmark Loans 125.0 bps, RFR Loans 125.0 bps, ABR Loans 25.0 bps, Undrawn Commitment Fee 12.5 bps
• ·Alternate Currencies include Euros and Pounds Sterling
• ·Agreed Currencies: U.S. Dollars and Alternate Currencies

06-04-2026

Encore Medical, Inc. filed Amendment No. 4 to its Form S-1 registration statement (No. 333-290244) on April 3, 2026, as an exhibit-only filing to add Exhibit 4.3 (Form of 2021–2022 Investor’s Warrant) and Exhibit 107 (Filing Fee Table), with no changes to the prospectus or other sections. The company is classified as an emerging growth company, smaller reporting company, and non-accelerated filer. This amendment supports the ongoing IPO process with commencement of proposed sale to the public as soon as practicable after effectiveness.

• ·Incorporated in Minnesota; I.R.S. Employer Identification Number: 82-2906303.
• ·Principal executive offices: 2975 Lone Oak Drive, Suite 140, Eagan, MN 55121.
• ·Primary Standard Industrial Classification Code Number: 3841.
• ·Agent for service: Joseph A. Marino at company address.

06-04-2026

Innovative Food Holdings, Inc. (IVFH) filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders on May 19, 2026, at 10:00 a.m. ET in Broadview, IL, soliciting votes on Proposal 1 (election of five directors), Proposal 2 (ratification of auditors), and Proposal 3 (advisory say-on-pay vote). As of the March 31, 2026 record date, 54,649,479 shares of common stock ($0.0001 par value) were outstanding and entitled to vote, with a majority required for quorum and approvals. The company uses the SEC's Notice and Access model for proxy materials distribution, with voting available via internet, phone, mail, or in person by May 18, 2026.

• ·Proxy materials and Annual Report for fiscal year ended December 31, 2025 available at www.proxyvote.com.
• ·Voting deadline: 11:59 p.m. ET on May 18, 2026 for internet and phone votes.
• ·Proposals 1 (Director Election) and 3 (Say-on-Pay) are non-routine (broker non-votes have no effect); Proposal 2 (Auditors) is routine.
• ·Stockholder list available for examination 10 days prior to meeting by calling (239) 596-0204.

06-04-2026

Mountain Crest Acquisition 6 Corp., a blank check company (SPAC), filed an S-1 registration statement on April 6, 2026, for an IPO with units to list on Nasdaq under symbols MCAH and MCAHR upon separate trading. The filing extensively discloses risks of pursuing a business combination with PRC-based targets, including VIE structure uncertainties, CSRC filing requirements, cybersecurity reviews, and potential government interventions that could render securities worthless. No specific business combination target or financial performance data is provided, emphasizing pre-operational status with no subsidiaries, dividends, or cash transfers to date.

• ·CSRC Trial Measures promulgated February 17, 2023, effective March 31, 2023.
• ·New Measures for Cybersecurity Review effective February 15, 2022.
• ·CSRC filing exemptions for prior listings completed before September 30, 2023.
• ·Risk factors detailed starting on page 81, including VIE enforceability and currency controls on page 98.
• ·No permissions required from PRC authorities like CSRC or Cyberspace Administration of China for this offering as of prospectus date.

06-04-2026

STRATEGIC ACQUISITIONS INC reported a reduced net loss of $40,223 for the year ended December 31, 2025, compared to $123,716 in 2024 (restated), driven by lower operating expenses ($40,223 vs. $144,822) and elimination of interest expense. However, revenue dropped to $0 from $43,671, primarily due to no interest income from Bitcoin-collateralized loans after full principal repayment in 2024, while cash plummeted 98% to $508 and total assets declined 78% to $5,388 amid reduced liabilities to $13,319.

• ·Basic and diluted net loss per share improved to $(0.01) from $(0.02).
• ·Net cash used in operating activities decreased to $30,473 from $110,124.
• ·Stockholders’ equity deficit narrowed to $(7,931) from $(81,029).
• ·Non-cash capital contribution of $11,000 for expenses paid on behalf of the company in 2025.
• ·No loans receivable or digital asset collateral remaining at end of 2025.

06-04-2026

On April 3, 2026, Donald A. Moul, President and Chief Executive Officer of Tennessee Valley Authority (TVA), notified the company and its Board of Directors of his intention to retire effective July 1, 2026. This announcement was filed in an 8-K on April 6, 2026, under Item 5.02. No successor has been named in the filing.

• ·Filing signed by Thomas C. Rice on April 3, 2026.

06-04-2026

Aperture AC, a Cayman Islands blank check company, filed Amendment No. 2 to its S-1 registration statement for an initial public offering of 9,000,000 units at $10.00 each, aiming to raise $90,000,000, with an underwriters' over-allotment option for up to 1,350,000 additional units. The sponsor, Aperture Sponsor LLC, holds 3,828,082 Class B founder shares (purchased for $25,000) designed to represent 27% ownership post-IPO (subject to potential surrender of up to 499,315 shares), and has committed to a simultaneous private placement of 267,500 units for $2,675,000. Public shareholders will have redemption rights upon a business combination, but face immediate dilution from low-cost founder shares and potential anti-dilution adjustments.

• ·Registrant is a non-accelerated filer, smaller reporting company, and emerging growth company.
• ·Principal executive offices: 835 Wilshire Blvd. 5th Floor, Los Angeles, CA 90017; prior address referenced as 28 N 3rd St., Apt A404, Alhambra, CA 91801.
• ·SEC file number: 333-291583; fiscal year end: December 31.
• ·15% aggregate redemption limit for shareholders acting in concert if shareholder vote on business combination.
• ·Founder shares convertible to Class A on 1:1 basis (subject to anti-dilution adjustments maintaining ~27% ownership).

06-04-2026

Shareholders of XAI Octagon Floating Rate & Alternative Income Trust (XFLT) and XAI Madison Equity Premium Income Fund (MCN) are solicited to vote at the joint annual meeting on May 7, 2026, to elect Scott Craven Jones and William T. Meyers as Class III Trustees for each fund, serving until the 2029 annual meeting. The Board of Trustees unanimously recommends voting 'FOR' the nominees, with the record date set as March 27, 2026. As of the record date, XFLT had 15,230,918 common shares and 7,300,000 preferred shares outstanding, while MCN had 21,116,722 common shares outstanding.

• ·Meeting location: 321 N. Clark Street, Suite 2430, Chicago, IL 60606 at 9:00 a.m. Central time.
• ·Vote required: Affirmative vote of a majority of shares present in person or by proxy at meeting with quorum.
• ·Proxy solicitation allows voting by mail, telephone, or internet; in-person voting requires ID and proof of ownership.

06-04-2026

XAI Octagon Floating Rate & Alternative Income Trust (XFLT) and XAI Madison Equity Premium Income Fund (MCN) have issued a joint proxy statement for their annual meeting on May 7, 2026, to elect Scott Craven Jones and William T. Meyers as Class III Trustees for each fund, serving until the 2029 annual meeting. The Board of Trustees unanimously recommends voting FOR the nominees. As of the record date of March 27, 2026, XFLT had 15,230,918 common shares and 7,300,000 preferred shares outstanding, while MCN had 21,116,722 common shares outstanding.

• ·Annual Meeting location: 321 N. Clark Street, Suite 2430, Chicago, IL 60606 at 9:00 a.m. Central time
• ·Record date: close of business on March 27, 2026
• ·Shareholder contact: (888) 903-3358
• ·XFLT shares: Common par value $0.01 per share; Preferred: Series A Mandatory Redeemable Preferred Shares
• ·MCN shares: Common par value $0.01 per share; No preferred shares
• ·Vote required: Majority of shares present in person or by proxy at meeting with quorum

06-04-2026

The Honest Company, Inc. entered into the First Amendment to its Credit Agreement and Pledge and Security Agreement, both originally dated January 25, 2023, as of March 31, 2026, subject to conditions precedent including executed documents, legal opinions, secretary certificates, and representations of no Default or Event of Default. The amendments update specific sections, schedules, exhibits, and render Section 2 of the Fee Letter inapplicable, while ratifying the existing loan documents without waiving any rights or remedies. No quantitative changes to facility terms are disclosed in the filing.

• ·Amendment filed as 8-K on April 06, 2026 (Items 1.01, 1.02, 2.03, 9.01).
• ·Governed by laws of the State of California.
• ·Executed in counterparts with electronic signatures permitted.

06-04-2026

Trustwave Securities Limited (formerly Sterling Guaranty & Finance Limited) intimated BSE Limited under Regulation 30 of SEBI (LODR) Regulations, 2015, that the Ministry of Corporate Affairs registered the Hon’ble NCLT order dated March 19, 2026, approving the scheme of reduction in share capital on April 6, 2026. The registration was filed via e-form INC-28, with a copy enclosed as Annexure A. No financial impacts or performance metrics are disclosed in the filing.

• ·CIN: L65990MH1983PLC031384
• ·Scrip Code: 508963
• ·ISIN: INE668Y01016
• ·Registered Office: B-702, 7th Floor, Neelkanth Business Park, Kirol Village, Near Bus Depot, Vidyavihar (W), Mumbai – 400086

06-04-2026

JPMorgan Chase & Co.'s 2026 proxy statement highlights record 2025 financial performance, including managed revenue of $185.6 billion, net income of $57.0 billion, ROE of 17%, and ROTCE of 20%, reflecting strong business execution and shareholder value creation. The document details robust board governance, recent committee reassignments, leadership under James Dimon, and support for the Security and Resiliency Initiative, with no material declines or flat metrics reported. The annual shareholder meeting is set for May 19, 2026, virtually at 10:00 a.m. ET.

• ·Annual shareholder meeting on May 19, 2026 at 10:00 a.m. Eastern Time, virtual format.
• ·Board meets at least eight times per year with independent director sessions.
• ·Recent committee changes: Ginni Rometty as Chair of Corporate Governance & Nominating Committee; Alex Gorsky and Michele Buck joined CGNC; Brad Smith and Alicia Boler Davis joined Public Responsibility Committee.

06-04-2026

Greenpro Capital Corp. consummated a Share Exchange Agreement on March 31, 2026, acquiring 1,360 ordinary shares of Forekast Limited (13.6% of its outstanding equity on a fully diluted basis) in exchange for issuing 8,500,000 shares of its common stock to Forekast shareholders. This nearly doubled outstanding shares from 8,625,813 to 17,125,813, significantly diluting existing ownership, with directors and officers' collective stake dropping from 39.67% to 19.98% and principal shareholders now holding 52.88%. The transaction was a minority investment without gaining control of Forekast.

• ·BHL Ltd. received 3,250,000 Company shares for 520 Forekast shares (previously 5.2% Forekast owner).
• ·Moira Venture Limited, Renhari Limited, Joharne Limited, Crescent East Limited, and Stratifi Global Limited each received 1,125,000 Company shares for 180 Forekast shares (previously 1.8% each).
• ·Exchange Shares issued under Rule 506 of Regulation D as restricted securities.

06-04-2026

Ashoka Refineries Ltd submitted the Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026, to BSE Limited. The certificate from Registrar and Share Transfer Agent Beetal Financial & Computer Services Pvt. Ltd. confirms that securities received for dematerialization were accepted/rejected to depositories, listed on stock exchanges, and certificates mutilated and cancelled within 15 days. This is a routine compliance filing with no financial or operational impacts disclosed.

• ·Filing reference: ARL/BSE/2026-27/02, dated April 6, 2026
• ·Certificate reference: BTL/Q4-2025-2026/21, dated April 3, 2026
• ·Company CIN: L15143CT1991PLC006678
• ·Beetal SEBI Reg. No.: INR 000000262

06-04-2026

Inflection Point Acquisition Corp. VI, a blank check company, consummated its IPO on March 30, 2026, issuing 25,300,000 units at $10.00 per unit for gross proceeds of $253,000,000, including 3,300,000 units from the underwriters' over-allotment option. Simultaneously, it completed a private placement of 7,400,000 warrants at $1.00 each to its sponsor and Cantor Fitzgerald & Co., generating $7,400,000. A total of $253,000,000 was placed in trust, with the balance sheet reflecting total assets of $255,206,776 but a shareholders' deficit of $10,024,533 due to offering costs and accumulated deficit.

• ·Promissory note – related party: $36,858
• ·Accrued offering costs: $103,232
• ·Transaction costs breakdown: $4,400,000 cash underwriting fee + $12,045,000 deferred + $832,094 other
• ·Company inception: September 12, 2025
• ·Fiscal year end: December 31
• ·Business Combination requirement: target fair market value at least 80% of trust net assets
• ·IPO registration statement effective: March 26, 2026

06-04-2026

Madison Air Solutions Corp's S-1/A filing highlights significant risks ahead of its IPO, including material weaknesses in internal controls, limited public company experience, tax uncertainties, and substantial indebtedness totaling $3,977.7 million as of December 31, 2025. While cash flows from operating activities increased sharply to $480.0 million in FY2025 from $220.4 million in FY2024 (+118% YoY), debt service cash outflows rose to $549.2 million (68% of operating cash flows before interest), up from $318.9 million in FY2024. Post-offering, expected annual debt service is projected to decline to $208.9 million, all interest-related.

• ·Sixth Amendment to Credit Agreement entered March 20, 2026, providing for 2026 Incremental Revolving Facility, effective post-offering.
• ·Tax Matters Agreement requires indemnification of Madison Industries International for certain tax liabilities from Organizational Transactions.
• ·Transition Services Agreement with Madison Industries International for tax compliance and other services post-separation.

06-04-2026

Mahaveer Infoway Limited has filed a disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, declaring that the Promoter/Promoter Group made no encumbrance of shares, directly or indirectly, during the financial year ended March 31, 2026. The declaration, signed by Ashok Kumar Jain (Managing Director), lists 13 promoters including Rajender Kumar Jain, Basanta Bai Jain, and others. This filing reassures investors of no pledges or liens on promoter holdings for the period.

• ·Company CIN: L65910TG1991PLC012704
• ·Address: 24/2/C, 301/A, DHANSI SURABHI COMPLEX, GREENLANDS, BEGUMPET, HYDERABAD, TELANGANA-500016
• ·Filing submitted to BSE Limited (Scrip code: 539383)

06-04-2026

INOVIO Pharmaceuticals, Inc. (Nasdaq: INO) announced a proposed underwritten public offering of shares of its common stock and accompanying Series A and Series B warrants (or pre-funded warrants in lieu thereof), all to be sold by the company. Piper Sandler is acting as sole manager, with INOVIO intending to grant a 30-day underwriter option to purchase up to 15% additional securities under the same terms. The offering is subject to market conditions, with no assurance of completion, size, or terms, and will be made via a prospectus supplement to a previously effective shelf registration.

• ·Shelf registration statement filed with SEC on November 9, 2023, and declared effective on January 31, 2024.
• ·Prospectus available via Piper Sandler at (800) 747-3924 or prospectus@psc.com.
• ·INOVIO focused on DNA medicines for HPV-related diseases, cancer, and infectious diseases.

06-04-2026

Legence Corp. filed an S-1 registration statement on April 6, 2026, presenting unaudited pro forma condensed combined financial information reflecting its acquisition of The Bowers Group, Inc. (Bowers) completed on January 2, 2026, for total estimated consideration of $426.6 million, including $283.1 million cash, 2,551,672 shares of Class A common stock valued at $98.6 million, and $44.9 million deferred consideration. Pro forma combined revenue for the year ended December 31, 2025, reaches $3,449,898 thousand, combining Legence's historical $2,550,491 thousand with Bowers' $902,357 thousand after adjustments, while pro forma total assets stand at $3,265,176 thousand as of December 31, 2025. The acquisition was financed via a $200.0 million incremental term loan, cash on hand, and revolver borrowings, following Legence's prior IPO in September 2025 which raised net proceeds of $780.2 million.

• ·Pro forma combined total liabilities as of December 31, 2025: $2,390,907 thousand.
• ·Pro forma combined total equity as of December 31, 2025: $874,269 thousand.
• ·IPO commenced trading on Nasdaq Global Select Market on September 12, 2025, and closed on September 15, 2025.
• ·Acquisition shares subject to lock-up through March 10, 2026.

06-04-2026

Kabra Commercial Limited, as Acquirer/Promoter, has appointed Intelligent Money Managers Private Limited as the Merchant Banker/Manager to the Offer for the proposed voluntary delisting of equity shares of Kabra Marble Udyog Ltd from The Calcutta Stock Exchange Limited. This appointment complies with Regulation 9 of the SEBI (Delisting of Equity Shares) Regulations, 2021. The contact details for the Merchant Banker include Mr. Amit Kumar Mishra at YMCA Building, 2nd Floor, 25, Jawaharlal Nehru Road, Kolkata – 700087.

• ·Scrip Code on BSE: 539393
• ·Scrip Code on CSE: 21038
• ·Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015

06-04-2026

NGL Fine-Chem Limited submitted the Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026, received from its Registrar and Share Transfer Agent, M/s. Purva Sharegistry (India) Pvt. Ltd. The filing confirms compliance with share transfer regulations and requests stock exchanges to take it on record. This is a routine regulatory compliance submission with no financial or operational impacts disclosed.

• ·Certificate pertains to share transfers for quarter ended March 31, 2026
• ·Scrip Code: 524774 (BSE), Symbol: NGLFINE (NSE)

06-04-2026

Neurocrine Biosciences (NBIX) has agreed to acquire Soleno Therapeutics (SLNO) for $53.00 per share in cash, representing a total equity value of $2.9 billion and premiums of 34% to the April 2, 2026 closing price and 51% to the 30-day VWAP. The deal adds VYKAT XR (diazoxide choline), which generated $190 million in 2025 revenue ($92 million in Q4), to Neurocrine's portfolio of first-in-class therapies including INGREZZA ($2.51 billion in 2025 revenue) and CRENESSITY ($301 million in 2025 revenue), strengthening its endocrinology and rare disease presence with IP extending into the mid-2040s. The transaction, funded by cash and modest debt without a financing condition, is expected to close within 90 days subject to regulatory approvals and customary conditions.

• ·PWS occurs in one in every 15,000 live births per Prader-Willi Syndrome Association USA.
• ·VYKAT XR approved by FDA in March 2025; CRENESSITY approved in December 2024.
• ·Neurocrine to host conference call at 8:00 AM ET on April 6, 2026.
• ·Advisors: Goldman Sachs & Co. LLC (financial, Neurocrine), Cooley LLP (legal, Neurocrine), Centerview Partners LLC and Guggenheim Securities, LLC (financial, Soleno), Wilson Sonsini Goodrich & Rosati (legal, Soleno).

06-04-2026

Neurocrine Biosciences has entered a definitive agreement to acquire Soleno Therapeutics for $53.00 per share in cash, representing a total equity value of $2.9 billion, a 34% premium to Soleno's April 2, 2026 closing price and 51% to its 30-day VWAP. The deal adds VYKAT XR, which generated $190 million in 2025 revenue including $92 million in Q4, to Neurocrine's portfolio alongside INGREZZA ($2.51 billion in 2025 revenue) and CRENESSITY ($301 million in 2025 revenue), supported by IP extending into the mid-2040s. The transaction is expected to close within 90 days, subject to customary conditions including regulatory approvals.

• ·VYKAT XR FDA approved March 2025, launched Q2 2025; CRENESSITY approved December 2024
• ·Transaction funded by cash on hand and modest pre-payable debt; not subject to financing condition
• ·Neurocrine conference call at 8:00 AM ET on April 6, 2026
• ·VYKAT XR IP estate expected to extend into mid-2040s

06-04-2026

Narayana Hrudayalaya Limited submitted a revised Scrutinizer’s Report correcting a clerical error in the number of equity shareholders attending the NCLT-convened meeting on April 02, 2026, from 41 to 43, with no impact on voting outcomes. The Scheme of Arrangement (demerger) between NH Integrated Care Private Limited and Narayana Hrudayalaya Limited received near-unanimous approval: 99.9999% of equity votes (20,43,60,804 total polled out of eligible), 100% from secured creditors (5 total, 8,38,09,44,465 votes), and 100% from unsecured creditors (3,71,29,56,371 votes). A negligible 0.0084% of public non-institution votes were against.

• ·Equity meeting held via VC/OAVM on April 02, 2026 at 10:00 A.M. IST; remote e-voting March 30 to April 01, 2026.
• ·Secured creditors meeting on April 02, 2026 at 11:30 A.M. IST; all 5 attended.
• ·Unsecured creditors meeting on April 02, 2026 at 12:30 P.M. IST.
• ·Record date for equity shareholders: implied February 20, 2026; e-voting cut-off March 26, 2026.
• ·NCLT order dated February 13, 2026 in C.A. (CAA) 50/BB/2025.

06-04-2026

Stanpacks (India) Ltd. submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2026. The certificate from the Registrar and Share Transfer Agent confirms that dematerialized and rematerialized share certificates were listed on the stock exchange, verified, mutilated, cancelled, and the depository substituted as registered owner within 15 days. This is a routine compliance filing with no financial impact.

• ·Scrip Code: 530931
• ·Filing reference: SSE-4/2026-2027

06-04-2026

Aban Offshore Limited, currently undergoing Corporate Insolvency Resolution Process (CIRP) under the IBC, disclosed the NCLAT Chennai order dated 27 March 2026 in Company Appeal (AT)(CH)(Ins) No.477/2025 filed by suspended MD Reji Abraham against Punjab National Bank. The tribunal noted rejection of the appellant's One Time Settlement (OTS) proposal, directed amendment of the appeal to include Resolution Professional Shailesh Desai as a party, and scheduled the next hearing for 10 April 2026. No financial resolutions or settlements were achieved, with proceedings continuing amid prior IRP substitution following their demise.

• ·Appeal references prior hearings on 26.09.2025 and 21.01.2026
• ·Auction notice issued by RP on 22.12.2025
• ·Filing submitted via BSE Listing Centre and NEAPS on 06 April 2026

06-04-2026

Tulive Developers Limited has constituted a Committee of Independent Directors, chaired by Mr. Jacob George Kandathil with members Mr. Pradeep Bhandari and Mrs. Bhumika Jignesh Shah, to provide reasoned recommendations on the Voluntary Delisting Offer from BSE Limited pursuant to SEBI Delisting Regulations. This follows the Detailed Public Announcement published on April 06, 2026. The recommendations, along with voting pattern details, will be published at least two working days before the bidding period in the same newspapers and sent to the stock exchange and Saffron Capital Advisors Private Limited.

• ·Scrip Code: 505285
• ·Detailed Public Announcement published on April 06, 2026 in Financial Express (English, all editions), Jansatta (Hindi, all editions), and Navshakti (Marathi, Mumbai edition)
• ·Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• ·Atul Gupta DIN: 01608328

06-04-2026

Tirupati Fincorp Ltd disclosed under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, that it does not have any promoters for the financial year ended March 31, 2026. The disclosure was submitted to BSE Limited on April 06, 2026, and signed by Anita Ramesh Chougule, Company Secretary & Compliance Officer.

• ·Scrip Code: 539008
• ·Disclosure pertains specifically to absence of promoters as defined under Regulation 31(4)

06-04-2026

UltraTech Cement Limited disclosed a material price movement (MPM) in its share price on April 6, 2026, but clarified there was no event, information, or impending announcement in mainstream media to trigger it, attributing it to purely market-driven factors. The filing was made under Regulation 30(11) of SEBI (LODR) Regulations, 2015, to BSE and NSE. It was signed by Dhiraj Kapoor, Company Secretary and Compliance Officer.

• ·Scrip Code BSE: 532538; NSE: ULTRACEMCO
• ·CIN: L26940MH2000PLC128420
• ·Registered Office: Ahura Centre, B – Wing, 2nd Floor, Mahakali Caves Road, Andheri (East), Mumbai 400 093, India

06-04-2026